Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)

Charlotte E. Rinnooy Kan; Heike Röckmann; Marijke R. van Dijk; Tanuja Ramsaransing; Lieke L. Reubsaet; Elke E.M. Peters; Lydia E. Vos

doi:10.1002/jvc2.273

Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)

Charlotte E. Rinnooy Kan
, Heike Röckmann
, Marijke R. van Dijk
, Tanuja Ramsaransing
, Lieke L. Reubsaet
, Elke E.M. Peters
, Lydia E. Vos^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

8 Downloads (Pure)

Abstract

Bullous cutaneous reactions can be caused by many factors, including vaccines.¹ However, among all cutaneous reactions following coronavirus disease 2019 (COVID-19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) COVID-19 vaccination, respectively.

Original language	English
Pages (from-to)	275-279
Number of pages	5
Journal	JEADV: Clinical Practice
Volume	3
Issue number	1
DOIs	https://doi.org/10.1002/jvc2.273
Publication status	Published - Mar 2024

Keywords

bullous cutaneous reaction
bullous eruption
COVID-19 mRNA vaccination
Pfizer and Moderna COVID-19 vaccination
reactive dermatitis

Access to Document

10.1002/jvc2.273Licence: CC BY-NC-ND

JEADV Clinical Practice - 2023 - Rinnooy Kan - Two cases with generalised bullous cutaneous reactions after COVID‐19 mRNAFinal published version, 5.94 MBLicence: CC BY-NC-ND

Cite this

@article{c50fd428cf4d4b09a2f59dc4e7e90750,

title = "Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax{\textregistered}) and Pfizer–BioNTech (Comirnaty{\textregistered})",

abstract = "Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID-19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax{\textregistered}) and Pfizer–BioNTech (Comirnaty{\textregistered}) COVID-19 vaccination, respectively.",

keywords = "bullous cutaneous reaction, bullous eruption, COVID-19 mRNA vaccination, Pfizer and Moderna COVID-19 vaccination, reactive dermatitis",

author = "\{Rinnooy Kan\}, \{Charlotte E.\} and Heike R{\"o}ckmann and \{van Dijk\}, \{Marijke R.\} and Tanuja Ramsaransing and Reubsaet, \{Lieke L.\} and Peters, \{Elke E.M.\} and Vos, \{Lydia E.\}",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors. JEADV Clinical Practice published by John Wiley \& Sons Ltd on behalf of European Academy of Dermatology and Venereology.",

year = "2024",

month = mar,

doi = "10.1002/jvc2.273",

language = "English",

volume = "3",

pages = "275--279",

journal = "JEADV: Clinical Practice",

publisher = "John Wiley \& Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)

AU - Rinnooy Kan, Charlotte E.

AU - Röckmann, Heike

AU - van Dijk, Marijke R.

AU - Ramsaransing, Tanuja

AU - Reubsaet, Lieke L.

AU - Peters, Elke E.M.

AU - Vos, Lydia E.

PY - 2024/3

Y1 - 2024/3

N2 - Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID-19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) COVID-19 vaccination, respectively.

AB - Bullous cutaneous reactions can be caused by many factors, including vaccines.1 However, among all cutaneous reactions following coronavirus disease 2019 (COVID-19) mRNA vaccines, bullous reactions are rare. Here, we describe two patients with delayed generalised bullous cutaneous reactions 7 days after receiving Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®) COVID-19 vaccination, respectively.

KW - bullous cutaneous reaction

KW - bullous eruption

KW - COVID-19 mRNA vaccination

KW - Pfizer and Moderna COVID-19 vaccination

KW - reactive dermatitis

UR - https://www.scopus.com/pages/publications/85186435887

U2 - 10.1002/jvc2.273

DO - 10.1002/jvc2.273

M3 - Article

AN - SCOPUS:85186435887

VL - 3

SP - 275

EP - 279

JO - JEADV: Clinical Practice

JF - JEADV: Clinical Practice

IS - 1

ER -

Two cases with generalised bullous cutaneous reactions after COVID-19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this